Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Infectious Diseases

• Publication date

  2009-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/599346PMID 19514856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.

  2008cited by this paper
• Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats

  2008cited by this paper
• The role of microbiota in infectious disease.

  2008cited by this paper
• Review article: the role of butyrate on colonic function

  2007cited by this paper
• Vancomycin‐resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high‐risk

  2007cited by this paper
• The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics

  2006cited by this paper
• Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.

  2006cited by this paper
• Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

  2005cited by this paper
• Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans.

  2005cited by this paper
• Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples.

  2005cited by this paper
• Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?

  2004cited by this paper
• Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients.

  2003cited by this paper
• Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria.

  2003cited by this paper
• The microbiology of butyrate formation in the human colon.

  2002cited by this paper
• Extensive Set of 16S rRNA-Based Probes for Detection of Bacteria in Human Feces

  2002cited by this paper
• Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

  2001cited by this paper
• Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting.

  2001cited by this paper
• Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora.

  2001cited by this paper
• Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview

  2000cited by this paper
• Total artificial nutrition is associated with major changes in the fecal flora

  2000cited by this paper
• Development and validation of an automated, microscopy-based method for enumeration of groups of intestinal bacteria.

  1999cited by this paper
• DGGE/TGGE a method for identifying genes from natural ecosystems.

  1999cited by this paper
• Treatment‐related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council Acute Myeloid Leukaemia Trial (MRC AML10)

  1999cited by this paper
• Temperature Gradient Gel Electrophoresis Analysis of 16S rRNA from Human Fecal Samples Reveals Stable and Host-Specific Communities of Active Bacteria

  1998cited by this paper
• Variations of Bacterial Populations in Human Feces Measured by Fluorescent In Situ Hybridization with Group-Specific 16S rRNA-Targeted Oligonucleotide Probes

  1998cited by this paper
• A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies

  1997cited by this paper
• Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment.

  1996cited by this paper
• Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples

  1995cited by this paper
• Rapid silver staining and recovery of PCR products separated on polyacrylamide gels.

  1994cited by this paper
• Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization

  1994cited by this paper
• Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA

  1993cited by this paper
• Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.

  1992cited by this paper
• Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations

  1990cited by this paper
• Antibacterial effect of etoposide in vitro

  1988cited by this paper
• Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.

  1985cited by this paper
• Antibacterial activities of antineoplastic agents

  1985cited by this paper
• [In vitro activity of several cytostatic drugs against aerobic and anaerobic intestinal bacteria].

  1984cited by this paper
• The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics.

  1984cited by this paper
• Fever and infection in leukemic patients. A study of 494 consecutive patients

  1978cited by this paper
• Colonization resistance of the digestive tract in conventional and antibiotic-treated mice

  1971cited by this paper
• Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

  1966cited by this paper

• L-Citrulline Improves Recovery of Enterocytes While Not Affecting Gut Microbiota in an In Vitro Model of Chemotherapy-Induced Gastrointestinal Mucositis

  2025cites this paper
• Effect of 5-Fluorouracil on Escherichia coli and Enterococcus spp.: insights into the selective pressures caused by this cytotoxic drug.

  2025cites this paper
• The role of the gut microbiota in chemotherapy response, efficacy and toxicity: a systematic review

  2025cites this paper
• Infectious Morbidity During Pediatric Acute Myeloid Leukemia Chemotherapy in a High‐Income Country: A 15‐Year Population‐Based Overview

  2025cites this paper
• Gut Microbiome and its Impact on Outcomes following Hematopoietic Stem Cell Transplantation: a Comprehensive Review

  2025cites this paper
• Microbiome in Neuroblastoma: A Virgin Island in the World of Onco-Microbiome

  2025cites this paper
• Changes in Gut Microbial Diversity and Correlation with Clinical Outcome in Children with Acute Myeloid Leukemia Receiving Induction Chemotherapy

  2025cites this paper
• Oral and intestinal flora translocation and tumor development.

  2025cites this paper
• Gut microbiome features and resistome elements associated with colonization and infection with antibiotic-resistance threats

  2025cites this paper
• Candida albicans gastrointestinal colonization resistance: a host-microbiome balancing act

  2025influential citation
• Escherichia coli extra-intestinal population translocation in leukemia patients

  2024cites this paper
• The Hazards of Probiotics on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice Undergoing Chemotherapy

  2024cites this paper
• Managing the Risk of Foodborne Infections in Pediatric Patients with Cancer: Is the Neutropenic Diet Still an Option?

  2024cites this paper
• Combined Dietary Supplementation of Tenebrio molitor Larvae and Chitosan in Growing Pigs: A Pilot Study

  2024cites this paper
• Gut Microbial Dysbiosis in the Pathogenesis of Leukemia: An Immune-based Perspective.

  2024cites this paper
• Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework

  2024cites this paper
• The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-Radiotherapy

  2024cites this paper
• Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities.

  2024cites this paper
• Effect of chemotherapeutic agents on natural transformation frequency in Acinetobacter baylyi

  2024cites this paper
• Effect of Chemotherapy on Fusobacterium nucleatum Abundance in Colorectal Cancer Patients: A Study on Relapsing Patients

  2024cites this paper
• Impact of the gut microbiome on response and toxicity to chemotherapy in advanced esophageal cancer

  2024cites this paper
• Promiscuous, persistent and problematic: insights into current enterococcal genomics to guide therapeutic strategy

  2024cites this paper
• CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance and immune homeostasis.

  2024cites this paper
• Pediatric Clostridioides difficile Infection: Essential Concepts, Management Nuances, and Updates

  2024cites this paper
• Multi-omics analysis of the gut microbiome and metabolites associated with the psychoneurological symptom cluster in children with cancer receiving chemotherapy

  2024cites this paper
• Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy

  2024cites this paper
• Crosstalk between gut microbiota and cancer chemotherapy: current status and trends

  2024cites this paper
• Genomic evidence of Escherichia coli gut population diversity translocation in leukemia patients

  2024cites this paper
• From odor to oncology: non-canonical odorant receptors in cancer

  2023cites this paper
• Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection

  2023cites this paper
• Serum, spleen metabolomics and gut microbiota reveals effect of catalpol on blood deficiency syndrome caused by cyclophosphamide and acetylphenylhydrazine

  2023cites this paper
• The Oxidative Stress and Nervous Distress Connection in Gastrointestinal Disorders

  2023cites this paper
• Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies.

  2023cites this paper
• Lactoferrin: Antimicrobial impacts, genomic guardian, therapeutic uses and clinical significance for humans and animals.

  2023cites this paper
• Altered intestinal microbiome and epithelial damage aggravate intestinal graft-versus-host disease

  2023cites this paper
• Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML

  2023cites this paper
• Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer

  2023cites this paper
• The effects of LactoCare synbiotic administration on chemotherapy‐induced nausea, vomiting, diarrhea, and constipation in children with ALL: A double‐blind randomized clinical trial

  2023cites this paper
• Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment

  2023cites this paper
• A Taxonomy-Agnostic Approach to Targeted Microbiome Therapeutics—Leveraging Principles of Systems Biology

  2023cites this paper
• Utilization of Tenebrio molitor Larvae Reared with Different Substrates as Feed Ingredients in Growing Pigs

  2023cites this paper
• Potential role of short-chain fatty acids in the pathogenesis and management of acute lymphocytic leukemia

  2023cites this paper
• Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition

  2023cites this paper
• Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss.

  2023cites this paper
• Prevention and Health Benefits of Prebiotics, Probiotics and Postbiotics in Acute Lymphoblastic Leukemia

  2023cites this paper
• Advances in the Study of Intestinal Flora in Acute Myeloid Leukemia

  2023cites this paper
• Manipulating the Gut Microbiome as a Therapeutic Strategy to Mitigate Late Effects in Childhood Cancer Survivors

  2023cites this paper
• Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease

  2023cites this paper
• The Gut Microbiome of Children during the COVID-19 Pandemic

  2022cites this paper
• The Prebiotic Effect of Australian Seaweeds on Commensal Bacteria and Short Chain Fatty Acid Production in a Simulated Gut Model

  2022cites this paper
• Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches

  2022cites this paper
• A Microbiota-Dependent Response to Anticancer Treatment in an In Vitro Human Microbiota Model: A Pilot Study With Hydroxycarbamide and Daunorubicin

  2022cites this paper
• Grading bloodstream infection risk using citrulline as a biomarker of intestinal mucositis in patients receiving intensive therapy

  2022cites this paper
• Oral administration of Euglena gracilis paramylon ameliorates chemotherapy-induced leukocytopenia and gut dysbiosis in mice.

  2022cites this paper
• Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature

  2022cites this paper
• A conserved enzyme found in diverse human gut bacteria interferes with anticancer drug efficacy

  2022cites this paper
• The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments

  2022cites this paper
• Changes in resistome profile of potential probiotic Lactiplantibacillus pentosus in response to edible oil adaptation.

  2022cites this paper
• Outcome and Determinants of Neutropenic Enterocolitis in Pediatric Cancer Patients

  2022cites this paper
• Effect of Paecilomyces cicadae polysaccharide Pc0-1 on cyclophosphamide-induced immunosuppression and regulation of intestinal flora in mice

  2022cites this paper
• Loss of microbiota-derived protective metabolites after neutropenic fever

  2022cites this paper
• Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies

  2022cites this paper
• Interaction of microbiome and immunity in tumorigenesis and clinical treatment.

  2022cites this paper
• The effect of neonatal nursing care on clinical symptoms and intestinal flora of children with acute diarrhea.

  2022cites this paper
• Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism

  2022cites this paper
• Microbial and host factors contribute to bloodstream infection in a pediatric acute lymphocytic leukemia mouse model

  2022cites this paper
• Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment

  2022cites this paper
• A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers

  2022cites this paper
• Gastrointestinal microbiota profile and clinical correlations in advanced EGFR-WT and EGFR-mutant non-small cell lung cancer

  2022cites this paper
• Microbiome-targeted interventions during gastrointestinal mucositis

  2022cites this paper
• The interplay between anticancer challenges and the microbial communities from the gut

  2022cites this paper
• Implications of Gut Microbiota in Epithelial–Mesenchymal Transition and Cancer Progression: A Concise Review

  2022cites this paper
• Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study

  2022cites this paper
• Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora

  2022cites this paper
• Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction.

  2022cites this paper
• Prospects of Probiotic Adjuvant Drugs in Clinical Treatment

  2022cites this paper
• Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis

  2021cites this paper
• Approaching precision medicine by tailoring the microbiota

  2021cites this paper
• The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets

  2021cites this paper
• Gut Microbiota in Lung Cancer: Where Do We Stand?

  2021cites this paper
• The role of microbiota in allogeneic hematopoietic stem cell transplantation

  2021cites this paper
• Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure

  2021cites this paper
• Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer

  2021cites this paper
• The Role of Oxidative Stress and Inflammation in Cardiometabolic Health of Children During Cancer Treatment and Potential Impact of Key Nutrients

  2021influential citation
• Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles

  2021cites this paper
• Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

  2021cites this paper
• Gut Microbiome and Cancer

  2021cites this paper
• Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation

  2021cites this paper
• Роль микробиома в патогенезе инфекционного и иммунологического повреждения желудочно-кишечного тракта у детей с онкогематологическими заболеваниями

  2021cites this paper
• The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer

  2021cites this paper
• The microbiome role in pathogenesis of inflammatory and immune alterations of gastrointestinal tract in pediatric patients with cancer

  2021cites this paper
• Human Microbiome: Understanding the Role of the Gut Microbiome and Implications for Oncology Nursing Care.

  2021cites this paper
• Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies

  2021cites this paper
• Gut microbiome in pediatric acute leukemia: from predisposition to cure

  2021cites this paper
• The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy.

  2021cites this paper
• Effect of chemotherapy and weight change on the gut microbiome of breast cancer patients during the first year of treatment

  2021cites this paper
• Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice

  2020cites this paper
• Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam

  2020cites this paper
• A new insight into acute lymphoblastic leukemia in children: influences of changed intestinal microfloras

  2020cites this paper
• Chemotherapy‐induced diarrhoea in dogs and its management with smectite: Results of a monocentric open‐label randomized clinical trial

  2020cites this paper